Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 17.35%302.17M | 17.35%302.17M | 12.62%266M | -6.81%203.31M | -29.35%221.51M | -15.94%257.51M | -15.94%257.51M | -17.55%236.2M | -31.34%218.17M | 27.41%313.52M |
-Cash and cash equivalents | 17.35%302.17M | 17.35%302.17M | 11.67%263.76M | -6.81%203.31M | -29.35%221.51M | -15.94%257.51M | -15.94%257.51M | -17.55%236.2M | -31.34%218.17M | 27.41%313.52M |
-Short-term investments | ---- | ---- | --2.24M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Receivables | -17.49%2.41B | -17.49%2.41B | -19.58%2.53B | -17.10%2.64B | -19.53%2.74B | -17.29%2.92B | -17.29%2.92B | -19.00%3.15B | -17.57%3.19B | -10.52%3.41B |
-Accounts receivable | -6.56%38.73M | -6.56%38.73M | 11.56%85.25M | -23.54%40.89M | -4.79%40.92M | 1.85%41.45M | 1.85%41.45M | 91.08%76.42M | 1.71%53.48M | -28.52%42.98M |
-Loans receivable | -17.74%2.35B | -17.74%2.35B | -20.46%2.43B | -17.02%2.58B | -19.76%2.69B | -17.54%2.86B | -17.54%2.86B | -20.12%3.06B | -17.84%3.11B | -10.11%3.35B |
-Taxes receivable | -2.01%16.3M | -2.01%16.3M | -1.04%16.6M | -11.99%16.6M | -12.88%16.62M | -12.99%16.63M | -12.99%16.63M | -23.24%16.78M | -15.57%18.86M | -27.16%19.08M |
Restricted cash | 42.01%148.52M | 42.01%148.52M | 80.01%175.38M | 0.99%85.42M | 5.89%84.74M | 13.05%104.58M | 13.05%104.58M | -87.67%97.43M | -89.56%84.59M | -90.46%80.02M |
Total current assets | -13.22%2.86B | -13.22%2.86B | -14.40%2.98B | -15.25%2.96B | -19.29%3.07B | -15.97%3.3B | -15.97%3.3B | -29.85%3.48B | -30.12%3.49B | -22.31%3.8B |
Non current assets | ||||||||||
Net PPE | 5.18%23.24M | 5.18%23.24M | 4.88%24.07M | 6.38%24.89M | 6.14%25.71M | -12.45%22.09M | -12.45%22.09M | -11.26%22.95M | -12.26%23.4M | -11.85%24.22M |
-Gross PPE | 5.18%23.24M | 5.18%23.24M | 4.88%24.07M | 6.38%24.89M | 6.14%25.71M | -12.45%22.09M | -12.45%22.09M | -11.26%22.95M | -12.26%23.4M | -11.85%24.22M |
Goodwill and other intangible assets | -20.01%47.17M | -20.01%47.17M | -17.24%49.57M | -13.02%50.48M | 6.75%54.58M | 9.25%58.97M | 9.25%58.97M | 9.22%59.89M | -0.55%58.03M | -18.45%51.13M |
-Other intangible assets | -20.01%47.17M | -20.01%47.17M | -17.24%49.57M | -13.02%50.48M | 6.75%54.58M | 9.25%58.97M | 9.25%58.97M | 9.22%59.89M | -0.55%58.03M | -18.45%51.13M |
Investments and advances | -0.71%2.24M | -0.71%2.24M | ---- | -19.89%2.24M | -19.32%2.25M | -25.83%2.25M | -25.83%2.25M | -16.19%2.61M | -36.68%2.79M | -86.47%2.79M |
Financial assets | --0 | --0 | --0 | --0 | -96.42%77K | -89.76%164K | -89.76%164K | -66.00%1.27M | -26.45%2.36M | 94.48%2.15M |
Non current deferred assets | -17.44%3.14M | -17.44%3.14M | -17.62%4.2M | -22.87%4.58M | -32.86%2.07M | -17.78%3.81M | -17.78%3.81M | -14.84%5.1M | -19.42%5.94M | -1.59%3.09M |
Other non current assets | 133.66%6.38M | 133.66%6.38M | 57.63%4.34M | -9.61%2.51M | 34.27%1.68M | 32.98%2.73M | 32.98%2.73M | -60.10%2.75M | -55.14%2.78M | -81.09%1.25M |
Total non current assets | -4.28%859.59M | -4.28%859.59M | -1.48%856.98M | -5.20%821.57M | 9.56%875.81M | 9.11%898M | 9.11%898M | 6.60%869.83M | 2.17%866.68M | -11.51%799.35M |
Total assets | -11.31%3.72B | -11.31%3.72B | -11.81%3.84B | -13.25%3.78B | -14.28%3.95B | -11.62%4.2B | -11.62%4.2B | -24.70%4.35B | -25.43%4.35B | -20.63%4.6B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -10.53%139.9M | -10.53%139.9M | -6.92%135.78M | -1.05%130.59M | 2.52%127.44M | 7.01%156.36M | 7.01%156.36M | -7.49%145.88M | -8.52%131.98M | -14.50%124.31M |
-accounts payable | 1.49%17.83M | 1.49%17.83M | 11.33%18.23M | -13.96%13.02M | 17.62%9.83M | 16.45%17.57M | 16.45%17.57M | -15.46%16.38M | -5.26%15.13M | -42.48%8.36M |
-Total tax payable | -12.62%21.15M | -12.62%21.15M | -3.39%22.47M | -6.90%21.9M | -7.44%22.8M | -7.62%24.2M | -7.62%24.2M | -7.26%23.26M | -13.13%23.53M | -30.28%24.64M |
-Dividends payable | -19.98%20.79M | -19.98%20.79M | -19.98%20.8M | 0.48%26.13M | 0.14%26.03M | 0.81%25.99M | 0.81%25.99M | 0.76%25.99M | 0.80%26M | 1.82%25.99M |
-Other payable | -9.56%80.13M | -9.56%80.13M | -7.45%74.27M | 3.30%69.54M | 5.29%68.78M | 12.08%88.6M | 12.08%88.6M | -8.22%80.25M | -10.73%67.32M | -6.69%65.32M |
Current accrued expenses | -11.29%10.05M | -11.29%10.05M | -7.40%8.96M | -3.69%7.29M | -1.61%12.51M | -3.05%11.32M | -3.05%11.32M | -18.52%9.68M | -11.30%7.57M | -3.75%12.72M |
Current debt and capital lease obligation | ---- | ---- | ---- | ---- | --1.03B | ---- | ---- | ---- | ---- | ---- |
-Current debt | ---- | ---- | ---- | ---- | --1.03B | ---- | ---- | ---- | ---- | ---- |
Current deferred liabilities | 8.77%7.85M | 8.77%7.85M | -1.39%7M | -3.62%6.98M | -44.03%6.86M | -6.10%7.22M | -6.10%7.22M | 0.33%7.1M | 12.06%7.24M | 6.49%12.25M |
Current liabilities | -9.78%157.8M | -9.78%157.8M | -6.71%151.74M | -1.31%144.86M | 689.36%1.18B | 5.69%174.9M | 5.69%174.9M | -7.92%162.65M | -7.83%146.79M | -12.25%149.28M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -8.15%2.52B | -8.15%2.52B | -9.51%2.6B | -12.18%2.53B | -49.18%1.57B | -14.15%2.74B | -14.15%2.74B | -31.62%2.87B | -31.78%2.88B | -25.03%3.09B |
-Long term debt | -8.27%2.49B | -8.27%2.49B | -30.75%1.97B | -33.55%1.9B | -49.63%1.55B | -14.17%2.72B | -14.17%2.72B | -31.75%2.84B | -31.92%2.86B | -25.13%3.07B |
-Long term capital lease obligation | 5.20%24.12M | 5.20%24.12M | 2,532.13%625.66M | 2,509.84%631.35M | 6.25%26.56M | -11.69%22.93M | -11.69%22.93M | -10.21%23.77M | -10.91%24.19M | -10.15%25M |
Other non current liabilities | -28.89%4.25M | -28.89%4.25M | -26.33%4.59M | -12.32%5.07M | 0.17%5.38M | 9.23%5.97M | 9.23%5.97M | 7.31%6.23M | -5.89%5.79M | -17.26%5.37M |
Total non current liabilities | -8.20%2.52B | -8.20%2.52B | -9.55%2.6B | -12.18%2.53B | -49.09%1.58B | -14.11%2.74B | -14.11%2.74B | -31.56%2.87B | -31.75%2.89B | -25.02%3.1B |
Total liabilities | -8.29%2.68B | -8.29%2.68B | -9.40%2.75B | -11.66%2.68B | -15.17%2.76B | -13.14%2.92B | -13.14%2.92B | -30.61%3.04B | -30.88%3.03B | -24.51%3.25B |
Shareholders'equity | ||||||||||
Share capital | -0.23%1.3M | -0.23%1.3M | -0.23%1.3M | 0.46%1.31M | 0.54%1.31M | 0.85%1.3M | 0.85%1.3M | 0.78%1.3M | 0.78%1.3M | 0.23%1.3M |
-common stock | -0.23%1.3M | -0.23%1.3M | -0.23%1.3M | 0.46%1.31M | 0.54%1.31M | 0.85%1.3M | 0.85%1.3M | 0.78%1.3M | 0.78%1.3M | 0.23%1.3M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -14.23%-1.81B | -14.23%-1.81B | -14.74%-1.77B | -15.24%-1.76B | -11.53%-1.67B | -8.16%-1.59B | -8.16%-1.59B | -6.85%-1.54B | -9.41%-1.53B | -6.35%-1.5B |
Paid-in capital | 0.02%2.87B | 0.02%2.87B | 0.01%2.86B | 0.34%2.87B | 0.35%2.86B | 0.39%2.86B | 0.39%2.86B | 0.35%2.86B | 0.22%2.86B | -0.12%2.85B |
Gains losses not affecting retained earnings | -147.93%-6.34M | -147.93%-6.34M | 11.26%-4.65M | 12.05%-5.05M | -48.59%-6.15M | -278.11%-2.56M | -278.11%-2.56M | 20.34%-5.24M | -1,026.47%-5.75M | -143.82%-4.14M |
Total stockholders'equity | -17.94%1.05B | -17.94%1.05B | -17.25%1.09B | -16.85%1.1B | -12.16%1.19B | -7.96%1.28B | -7.96%1.28B | -6.26%1.31B | -8.99%1.32B | -7.29%1.35B |
Noncontrolling interests | -312.82%-2.41M | -312.82%-2.41M | -189.96%-1M | -72.69%304K | -2.25%1.13M | -9.95%1.13M | -9.95%1.13M | -14.68%1.12M | -17.00%1.11M | -96.80%1.15M |
Total equity | -18.20%1.05B | -18.20%1.05B | -17.39%1.09B | -16.90%1.1B | -12.15%1.19B | -7.96%1.28B | -7.96%1.28B | -6.27%1.32B | -9.00%1.32B | -9.45%1.35B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |